Lista de obras -

21-Gene Recurrence Score Adds Significant Value for Grade 3 Breast Cancers: Results From a National Cohort

scientific article published on 14 August 2019

A Phase II Study of Sagopilone (ZK 219477; ZK-EPO) in Patients With Breast Cancer and Brain Metastases ⬇️

artículo científico publicado el 22 de junio de 2011

A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer

scientific article published on 06 October 2020

A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases

artículo científico publicado en 2013

A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast

artículo científico publicado en 2021

Abstract CT026: A phase II trial of neratinib (NER) or NER plus fulvestrant (FUL) (N+F) in HER2 mutant, non-amplified (HER2mut) metastatic breast cancer (MBC): Part II of MutHER

artículo científico publicado en 2021

Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527

artículo científico publicado en 2016

Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial

artículo científico publicado en 2019

Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors

scientific article published on 01 May 2018

Adjuvant chemotherapy for older patients with breast cancer: When is the pain worth the gain?

scientific article published on 15 October 2019

Adjuvant therapies for very young women with early stage breast cancer ⬇️

artículo científico publicado el 1 de octubre de 2011

Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer

scientific article published on 19 January 2010

Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101

artículo científico publicado en 2018

Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology

artículo científico publicado en 2019

Association of Breast Cancer Knowledge With Receipt of Guideline-Recommended Breast Cancer Treatment

artículo científico publicado en 2016

Black/White Disparities in Receipt of Treatment and Survival Among Men With Early-Stage Breast Cancer

artículo científico publicado en 2015

Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy Regimens.

artículo científico publicado en 2017

Breast cancer and aging: Standing on the shoulders of a giant

artículo científico publicado en 2019

Breast cancer-specific survival by age: Worse outcomes for the oldest patients

artículo científico publicado en 2018

Clinical Impact of Second Opinion Radiology Consultation for Patients With Breast Cancer

scientific article published on 20 December 2018

Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.

scientific article published on 17 May 2013

Developing a patient decision aid for women aged 70 and older with early stage, estrogen receptor positive, HER2 negative, breast cancer

artículo científico publicado en 2019

Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study

artículo científico publicado en 2014

Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors.

artículo científico publicado en 2016

Efficacy and safety in older patient subsets in studies of endocrine monotherapy versus combination therapy in patients with HR+/HER2- advanced breast cancer: a review

artículo científico publicado en 2017

Emerging Data and Current Challenges for Young, Old, Obese, or Male Patients with Breast Cancer

artículo científico publicado en 2017

Examining Associations of Racial Residential Segregation With Patient Knowledge of Breast Cancer and Treatment Receipt

scientific article published on 08 December 2018

Factors Associated with Early Mortality Among Patients with De Novo Metastatic Breast Cancer: A Population-Based Study

artículo científico publicado en 2017

Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013.

artículo científico publicado en 2017

Factors associated with radiation therapy incompletion for patients with early-stage breast cancer

artículo científico publicado en 2015

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

artículo científico publicado en 2017

Follow-up Care for Breast Cancer Survivors

artículo científico publicado en 2020

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer

artículo científico publicado en 2018

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer

artículo científico publicado en 2017

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

artículo científico publicado en 2020

Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the gene polymorphism

article

Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey

artículo científico publicado en 2015

How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab

artículo científico publicado en 2015

Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials

scientific article published on 15 November 2019

Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria

scientific article published on 03 August 2018

Impact of a Pre-Operative Exercise Intervention on Breast Cancer Proliferation and Gene Expression: Results from the Pre-Operative Health and Body (PreHAB) Study

scientific article published on 24 April 2019

Impact of treatment regimen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer

artículo científico publicado en 2017

Implementation of Surgeon-Initiated Gene Expression Profile Testing (Onco type DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation

artículo científico publicado en 2017

Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer

artículo científico publicado en 2019

Learning from social media: utilizing advanced data extraction techniques to understand barriers to breast cancer treatment

artículo científico publicado en 2016

Location Isn't Everything: Proximity, Hospital Characteristics, Choice of Hospital, and Disparities for Breast Cancer Surgery Patients

artículo científico publicado en 2016

Management of breast cancer in very young women

artículo científico

Managing metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer in the older patient

artículo científico publicado en 2013

Modern Trends in the Surgical Management of Paget's Disease

artículo científico publicado en 2015

Morbidity of local therapy for locally advanced metastatic breast cancer: an analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare Registry

artículo científico publicado en 2018

NI-23BRAIN BREAST METASTASES RESPOND TO ANTI-ANGIOGENIC THERAPY BY MODES OF VASCULAR NORMALIZATION

artículo científico publicado en 2014

Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.

artículo científico publicado en 2017

Older adult participation in cancer clinical trials: A systematic review of barriers and interventions

artículo científico publicado en 2020

Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715)

scientific article published on 11 April 2019

Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center

scientific article published on 16 September 2020

Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.

artículo científico publicado en 2016

Patterns of Axillary Management in Stages 2 and 3 Hormone Receptor-Positive Breast Cancer by Initial Treatment Approach

artículo científico publicado en 2019

Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast Cancer

artículo científico publicado en 2017

Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt

artículo científico publicado en 2017

Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy

artículo científico publicado en 2014

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

scientific article published on 30 November 2020

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022

artículo científico publicado en 2019

Prior Authorization for Medications in a Breast Oncology Practice: Navigation of a Complex Process.

artículo científico publicado en 2017

Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602).

artículo científico publicado en 2018

Racial differences in outcomes for patients with metastatic breast cancer by disease subtype

artículo científico publicado en 2015

Racial/Ethnic Differences in Patients' Selection of Surgeons and Hospitals for Breast Cancer Surgery

artículo científico publicado en 2015

Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care?

artículo científico publicado en 2013

Racial/ethnic disparities in knowledge about one's breast cancer characteristics

artículo científico publicado en 2015

Receipt of locoregional therapy among young women with breast cancer

artículo científico publicado en 2012

Reducing disparities in breast cancer care: a daunting but essential responsibility

scientific article published on 25 November 2008

Reply to K. Lin et al

scientific article published on 25 July 2016

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

artículo científico publicado en 2016

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update

artículo científico publicado en 2020

Standardized activities for lay patient navigators in breast cancer care: Recommendations from a citywide implementation study

artículo científico publicado en 2019

State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.

artículo científico publicado en 2017

Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review

artículo científico publicado en 2016

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases

scientific article published on 12 March 2019

Temporal Trends in and Factors Associated With Contralateral Prophylactic Mastectomy Among US Men With Breast Cancer

artículo científico publicado en 2015

The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer

artículo científico publicado en 2022

The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care ⬇️

artículo científico publicado el 11 de octubre de 2010

The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.

artículo científico publicado en 2015

Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.

artículo científico publicado en 2016

Translating research into practice: Protocol for a community-engaged, stepped wedge randomized trial to reduce disparities in breast cancer treatment through a regional patient navigation collaborative

scientific article published on 16 April 2020

Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases

artículo científico publicado en 2016

Treatment Patterns Among De Novo Metastatic Cancer Patients Who Died Within 1 Month of Diagnosis

scholarly article published June 2019

Treatment Patterns Among Women Diagnosed With Stage I-III Triple-negative Breast Cancer

artículo científico publicado en 2017

Treatment of early-stage human epidermal growth factor 2-positive cancers among medicare enrollees: age and race strongly associated with non-use of trastuzumab

artículo científico publicado en 2016

Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.

artículo científico

Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010.

artículo científico publicado en 2012

Trends in racial and age disparities in definitive local therapy of early-stage breast cancer

artículo científico publicado en 2008

Understanding Breast Cancer Knowledge and Barriers to Treatment Adherence: A Qualitative Study Among Breast Cancer Survivors

artículo científico publicado en 2017

Use of Surveillance Mammography Among Older Breast Cancer Survivors by Life Expectancy

artículo científico publicado en 2017

Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network ⬇️

artículo científico publicado el 25 de septiembre de 2012

Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)

artículo científico publicado en 2017

Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States

artículo científico publicado en 2018

Weathering the Storm: Managing Older Adults with Breast Cancer Amid COVID-19 and Beyond

artículo científico publicado en 2020

Who Are the Patients in Our Clinical Trials for Cancer?

scientific article published on 17 April 2019

Lista de obras de

21-Gene Recurrence Score Adds Significant Value for Grade 3 Breast Cancers: Results From a National Cohort

A Phase II Study of Sagopilone (ZK 219477; ZK-EPO) in Patients With Breast Cancer and Brain Metastases ⬇️

A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer

A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases

A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast

Abstract CT026: A phase II trial of neratinib (NER) or NER plus fulvestrant (FUL) (N+F) in HER2 mutant, non-amplified (HER2mut) metastatic breast cancer (MBC): Part II of MutHER

Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527

Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial

Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors

Adjuvant chemotherapy for older patients with breast cancer: When is the pain worth the gain?

Adjuvant therapies for very young women with early stage breast cancer ⬇️

Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer

Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101

Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology

Association of Breast Cancer Knowledge With Receipt of Guideline-Recommended Breast Cancer Treatment

Black/White Disparities in Receipt of Treatment and Survival Among Men With Early-Stage Breast Cancer

Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy Regimens.

Breast cancer and aging: Standing on the shoulders of a giant

Breast cancer-specific survival by age: Worse outcomes for the oldest patients

Clinical Impact of Second Opinion Radiology Consultation for Patients With Breast Cancer

Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.

Developing a patient decision aid for women aged 70 and older with early stage, estrogen receptor positive, HER2 negative, breast cancer

Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study

Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors.

Efficacy and safety in older patient subsets in studies of endocrine monotherapy versus combination therapy in patients with HR+/HER2- advanced breast cancer: a review

Emerging Data and Current Challenges for Young, Old, Obese, or Male Patients with Breast Cancer

Examining Associations of Racial Residential Segregation With Patient Knowledge of Breast Cancer and Treatment Receipt

Factors Associated with Early Mortality Among Patients with De Novo Metastatic Breast Cancer: A Population-Based Study

Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013.

Factors associated with radiation therapy incompletion for patients with early-stage breast cancer

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Follow-up Care for Breast Cancer Survivors

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the gene polymorphism

Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey

How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab

Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials

Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria

Impact of a Pre-Operative Exercise Intervention on Breast Cancer Proliferation and Gene Expression: Results from the Pre-Operative Health and Body (PreHAB) Study

Impact of treatment regimen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer

Implementation of Surgeon-Initiated Gene Expression Profile Testing (Onco type DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation

Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer

Learning from social media: utilizing advanced data extraction techniques to understand barriers to breast cancer treatment

Location Isn't Everything: Proximity, Hospital Characteristics, Choice of Hospital, and Disparities for Breast Cancer Surgery Patients

Management of breast cancer in very young women

Managing metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer in the older patient

Modern Trends in the Surgical Management of Paget's Disease

Morbidity of local therapy for locally advanced metastatic breast cancer: an analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare Registry

NI-23BRAIN BREAST METASTASES RESPOND TO ANTI-ANGIOGENIC THERAPY BY MODES OF VASCULAR NORMALIZATION

Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.

Older adult participation in cancer clinical trials: A systematic review of barriers and interventions

Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715)

Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center

Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.

Patterns of Axillary Management in Stages 2 and 3 Hormone Receptor-Positive Breast Cancer by Initial Treatment Approach

Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast Cancer

Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt

Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022

Prior Authorization for Medications in a Breast Oncology Practice: Navigation of a Complex Process.

Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602).

Racial differences in outcomes for patients with metastatic breast cancer by disease subtype

Racial/Ethnic Differences in Patients' Selection of Surgeons and Hospitals for Breast Cancer Surgery

Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care?

Racial/ethnic disparities in knowledge about one's breast cancer characteristics

Receipt of locoregional therapy among young women with breast cancer

Reducing disparities in breast cancer care: a daunting but essential responsibility

Reply to K. Lin et al

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update

Standardized activities for lay patient navigators in breast cancer care: Recommendations from a citywide implementation study

State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.

Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases

Temporal Trends in and Factors Associated With Contralateral Prophylactic Mastectomy Among US Men With Breast Cancer

The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer